Consult a healthcare practitioner prior to use if you have liver disease, kidney disease, and/or a seizure disorder
Fortinos weight loss clinic
Novo Nordisk A/S Key Target Audience Market Players Investors End-users Government Authorities Consulting and Research Firm Venture capitalists Value-Added Resellers (VARs) Recent Development In January 2023, Semaglutide (Wegovy- Novo Nordisk) has been licensed by the US Food and Drug Administration for the treatment of obesity in pediatric patients aged 12 and above
Study population Female patients aged 2040 years were identified based on a documented fertility-related encounter, defined as a medical visit associated with a diagnosis of female infertility, an encounter for procreative management (encompassing general counseling, fertility testing, and ART surveillance), or specific fertility treatments (e.g., intrauterine insemination, oocyte retrieval) (see codes in Supplementary Table S1)
My opinion is no, he concluded
Eat protein first before any other macronutrient